Explore our newsroom for Symani press releases, news stories, and journalist resources.
Stay up to date with the latest Symani news
Subscribe for timely email updates from MMI
"*" indicates required fields
MMI Completes World’s First Robotic Preclinical Study in Neurosurgery with Symani® Surgical System
What’s next for surgical robotics? Medtech vet Mark Toland places his bets
MMI Builds Global Momentum with Multiple Distribution Agreements and Regulatory Approvals
MMI Wins Innovative Start-up in 2024 Surgical Robotics Industry Awards
Robot-assisted surgery: Big step in the millimeter range
MMI Completes First Symani® Clinical Cases in the U.S. Following FDA Commercial Authorization
MMI Receives FDA Authorization to Commercialize Symani® Surgical System in the U.S.
MMI Raises $110 Million in Series C Financing
Micro Instruments, Massive Impact: The Surgibots Podcast featuring The Symani Surgical System
Medical Innovation Must Shift Focus from Common Problems to Unsolvable Ones
MMI and ab medica Partner to Expand Access to Symani® Surgical System
MMI to Present at the 42nd Annual J.P. Morgan Healthcare Conference
5022 Gate Parkway,
Building 500,
Jacksonville, FL 32256
The Symani Surgical System is authorized for use in the U.S. by the FDA and is a CE marked medical device. Clinical indications vary by geography. Refer to global indications for more information. © 2024 Medical Microinstruments, Inc. All Rights Reserved.